Get the app!
Back to Trades

Smith Ryan Lewis

DirectorCIK: 0001619129

Smith Ryan Lewis, Director, has filed 12 insider trading reports covering 2 companies. Total disclosed trading volume is $15.5M. The predominance of buying activity ($13.1K in purchases vs. $0 in sales) may reflect this insider's confidence in the underlying companies. The largest single filing involves 180 Life Sciences Corp. (ATNF). All transactions sourced from SEC Form 4 filings.

Total Volume
$15.5M
Purchases
$13.1K
Sales
$0
Companies
2

Trading History (12 filings)